Genmab A/S Files 6-K, Incorporates into S-8 Filings
Ticker: GNMSF · Form: 6-K · Filed: Sep 11, 2024 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | Sep 11, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, registration-statement, administrative
Related Tickers: GMAB
TL;DR
Genmab filed a 6-K on 9/11/24, linking it to their S-8 stock registration statements.
AI Summary
Genmab A/S filed a Form 6-K on September 11, 2024, to report information for the month of September 2024. This filing is incorporated by reference into several of Genmab's existing Form S-8 registration statements, including File Nos. 333-232693, 333-253519, 333-262970, and 333-277273.
Why It Matters
This filing serves to update or supplement information related to Genmab's employee stock plans, ensuring compliance and transparency for investors and participants.
Risk Assessment
Risk Level: low — This is a routine administrative filing that incorporates previous information into existing registration statements.
Key Players & Entities
- Genmab A/S (company) — Registrant
- 333-232693 (dollar_amount) — Form S-8 File Number
- 333-253519 (dollar_amount) — Form S-8 File Number
- 333-262970 (dollar_amount) — Form S-8 File Number
- 333-277273 (dollar_amount) — Form S-8 File Number
- September 11, 2024 (date) — Filing Date
FAQ
What type of SEC filing is this report?
This report is a Form 6-K, which is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
What is the primary purpose of this Form 6-K filing for Genmab A/S?
The primary purpose is to report information for the month of September 2024 and to be incorporated by reference into Genmab A/S's existing Form S-8 registration statements.
Which specific Form S-8 registration statements are mentioned in this filing?
The filing mentions Genmab A/S's registration statements on Form S-8 with File Numbers 333-232693, 333-253519, 333-262970, and 333-277273.
What is the filing date of this Form 6-K?
This Form 6-K was filed on September 11, 2024.
Does Genmab A/S file annual reports under Form 20-F or Form 40-F?
Genmab A/S indicates it files annual reports under Form 20-F.
Filing Stats: 210 words · 1 min read · ~1 pages · Grade level 14.1 · Accepted 2024-09-11 15:47:05
Filing Documents
- tmb-20240911x6k.htm (6-K) — 19KB
- tmb-20240911xex3d1.htm (EX-3.1) — 275KB
- 0001558370-24-012729.txt ( ) — 295KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE MONTH OF SEPTEMBER 2024 COMMISSION FILE NUMBER 001-38976 Genmab A/S (Exact name of Registrant as specified in its charter) Carl Jacobsens Vej 30 2500 Valby Denmark +45 70 20 27 28 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F This report on Form 6-K shall be deemed to be incorporated by reference in Genmab A/S's registration statements on Form S-8 (File No. 333-232693, 333-253519, 333-262970 and 333-277273 ) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. GENMAB A/S BY: /s/ Anthony Pagano Name: Anthony Pagano Title: Executive Vice President & Chief Financial Officer DATE: SEPTEMBER 11, 2024 EXHIBIT INDEX Exhibit Description of Exhibit 3.1 Articles of Association